Niko Skievaski

Niko Skievaski is the Co-Founder and CEO of Althea, a public benefit company focused on understanding the effects of psychedelic programs on health and consciousness, launched in partnership with CU Anschutz Psychiatry. Currently serving as a reporter covering psychedelics for Boulder Weekly, Niko has extensive experience as a board member for Prime Health, which accelerates the adoption of healthcare technologies, and as a co-founder of Boulder Health Tech, a meetup group for health and biotech professionals. Niko previously co-founded and served as President of Redox, a digital health integration platform, and has held advisory roles for various organizations, including Porter Metrics. Additionally, involvement in boards such as RISE Wisconsin and 100state reflects a commitment to community and entrepreneurial support. Niko's educational background includes a certificate from MIT Sloan School of Management in Artificial Intelligence and degrees in Economics from Boston University and Arizona State University.